Question

Difficulty: HardImmunologic and Inflammatory Processes

A 54-year-old female presents to an outpatient nephrology clinic for rapid-onset swelling in her lower extremities and dark urine. She also reports progressive joint stiffness in her hands and knees over the past month, accompanied by a new, non-itchy rash on her shins. Her past medical history is significant for a brief period of intravenous drug use in her early twenties, but she has not sought medical care in over a decade. Her vital signs include a blood pressure of 152/94 mmHg. Physical examination demonstrates 2+ pitting edema to the knees and scattered, palpable purpuric lesions across both lower legs.

Laboratory testing reveals:
Serum creatinine: 1.9 mg/dL (Baseline unknown)
Urinalysis: 3+ protein, 20-30 red blood cells/hpf, dysmorphic red cells present
Rheumatoid factor: 420 IU/mL (Normal: < 15 IU/mL)
Complement C3: 92 mg/dL (Normal: 80-160 mg/dL)
Complement C4: 6 mg/dL (Normal: 15-45 mg/dL)
Hepatitis C virus RNA: 2.1 x 10^6 IU/mL

Which of the following best describes the fundamental immunopathologic mechanism driving this patient's current presentation?

  1. A
    Mesangial deposition of aberrantly glycosylated IgA1-containing immune complexes
  2. B
    IgG autoantibody-mediated stabilization of the alternative complement pathway C3bBb convertase
  3. Formation of immune complexes by IgM autoantibodies binding to the Fc region of endogenous IgGAnswer
  4. D
    Production of IgG autoantibodies targeting myeloperoxidase within neutrophil primary granules
  5. E
    Direct binding of autoantibodies to the non-collagenous domain of type IV collagen in the basement membrane

Answer

Formation of immune complexes by IgM autoantibodies binding to the Fc region of endogenous IgG
The correct answer accurately describes the underlying pathogenesis of mixed cryoglobulinemia. In mixed cryoglobulinemia (Types II and III), which is heavily associated with chronic Hepatitis C infection, the body produces IgM autoantibodies that specifically target the Fc region of endogenous IgG. These IgM antibodies are clinically measured as Rheumatoid Factor, which is highly elevated in this patient. When these IgM-IgG immune complexes form and deposit in small to medium-sized blood vessels, they strongly activate the classical complement pathway by binding C1q. This extensive classical pathway activation disproportionately consumes early complement components, leading to a characteristically profound decrease in serum C4 levels while C3 levels often remain normal or only mildly depressed.

Step-by-Step Solution

1
Analyze the clinical syndrome presented in the vignette.
The patient exhibits the classic triad of palpable purpura, arthralgias, and weakness/fatigue, accompanied by new-onset glomerulonephritis (edema, hypertension, hematuria with dysmorphic RBCs). The history of intravenous drug use provides a strong risk factor for chronic viral hepatitis.
Identifying the overarching clinical syndrome narrows the differential diagnosis of systemic vasculitis with renal involvement.
2
Interpret the specific laboratory findings to identify the underlying immunopathologic mechanism.
The presence of Hepatitis C virus, highly elevated rheumatoid factor, and a profoundly depressed C4 level with a normal C3 level point directly to mixed cryoglobulinemia.
Rheumatoid factor is an IgM autoantibody against IgG. Hepatitis C is the most common trigger for mixed cryoglobulinemia (Type II or III). The isolated, severe C4 consumption confirms massive classical complement pathway activation by these specific immune complexes.

Key Concept

Mixed cryoglobulinemia (Type II and III) is strongly associated with chronic Hepatitis C infection and is driven by IgM autoantibodies (rheumatoid factor) forming immune complexes with endogenous IgG, leading to classical complement pathway activation and profound C4 consumption.
Rate this question